Grants in Spain
Explore grants for companies in Spain. This directory includes national and regional funding from Spanish innovation agencies, research funders and foundations, EU and international programs open to applicants in Spain, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Spain come first.
Showing 1,609-1,632 of 2,086 grants
High Priority HIV and Substance Use Research (R01)
NIH · United States
Funds research where HIV and drug use intersect. Preliminary data are compulsory, and the work must sit on NIH's published HIV priorities.
Opportunities for Collaborative Research at the NIH Clinical Center
NIH · United States
Funds a translational research project run jointly with NIH's own intramural investigators at the Clinical Center, up to $500,000.
Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances
NIH · United States
Funds building and pilot-testing an HIV prevention, treatment or services intervention for people who use drugs — behavioural, social, structural or combined.
UNITED STATES MILITARY ACADEMY Broad Agency Announcement
AMC · United States
Funds extramural research for West Point's academic centers, across eight named campaigns from weapons science to quantum computing.
MSCA Staff Exchanges 2027
European Commission · European Union
Funds secondments of staff between partner organisations worldwide so researchers and R&I staff gain cross-sector, cross-country and cross-discipline experience.
Supernova Challenge
GITEX CAC · United Arab Emirates
Pays equity-free cash prizes to exhibiting startups that pitch live on the main stage at GITEX AI Kazakhstan.
New Approaches for Measuring Brain Changes Across Longer Timespans (R01)
NIH · United States
Funds new or newly applied ways to measure brain activity, connectivity or genomics across the lifespan, to predict what happens later.
New Approaches for Measuring Brain Changes Across Longer Timespans (R21)
NIH · United States
Funds highly novel approaches to measuring brain activity, connectivity or genomics repeatedly across the lifespan, on an exploratory footing.
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders
NIH · United States
Funds pilot work before a larger trial of how addiction treatment and related services are delivered, paid for and reached.
BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development
NIH · United States
Funds next-generation sensors and bioelectronic devices that record behaviour in step with brain recordings, to build models of how the two connect.
Early-Stage Dissemination and Implementation Research in Communication Disorders
NIH · United States
Funds early-stage work on getting proven hearing, balance, taste, smell, voice and language treatments adopted in real clinics and daily life.
Cutting-Edge Basic Research Awards (CEBRA)
NIH · United States
Funds high-risk addiction research that is sparse or absent from the institute's current portfolio — a revolutionary method, or a hypothesis with no precedent.
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System
NIH · United States
Funds a biologic for a nervous system disorder from lead optimisation to phase I, with NIH-paid manufacturing and tox work — and the applicant keeps the IP.
Investigator Initiated Innovation in Computational Genomics and Data Science (R01)
NIH · United States
Funds computational genomics work — new analytical methods, early-stage tools, or hardening software the genomics community already relies on.
Investigator Initiated Innovation in Computational Genomics and Data Science (R21)
NIH · United States
Funds the exploratory version of the same computational genomics work — new methods, early tools, or hardening software the field depends on.
MSCA Postdoctoral Fellowships 2027
European Commission · European Union
Pays a postdoctoral researcher's fellowship at a host organisation in Europe, or abroad with a mandatory return phase, to build international research experience.
Integrating Biospecimen Science Approaches into Clinical Assay Development
NIH · United States
Funds research into how preanalytical handling of biopsies and other biospecimens distorts biomarker results used in clinical assays.
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies
NIH · United States
Funds technology anywhere in the connectomics pipeline — collection, reconstruction, analysis, dissemination — to make brain wiring diagrams faster and cheaper.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
NIH · United States
Funds research using a screening trial's biorepository — serial blood samples collected before diagnosis, with decades of matched participant data.
NIDCD Research Grants for Translating Basic Research into Clinical Practice
NIH · United States
Funds translational research turning basic findings into clinical tools for communication disorders, with practical clinical impact required.
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders
NIH · United States
Funds a confirmatory efficacy trial of a non-drug treatment or preventive intervention for mental disorders, in adults or children.
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33)
NIH · United States
Funds three years replicating target engagement for a psychosocial intervention and testing whether that engagement tracks clinical change.
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33)
NIH · United States
Funds two years establishing that a psychosocial intervention hits its target, then three replicating it and linking it to clinical change.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33)
NIH · United States
Funds early-stage testing of a novel-mechanism drug or a device for mental disorders, designed to show a dose-dependent effect on the target.